Skip to main content

Biomedical, Clinical & Life Sciences

RFA-IP-23-005: 2023 Approach to Adult Vaccine Counseling

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Notice of Funding Opportunity (NOFO) is to support research to: 1) obtain a better understanding of existing vaccination counseling practices for adults, particularly adults who may experience disproportionate burdens of vaccine-preventable diseases (e.g., pregnant women, racial or ethnic minority groups, those living in rural communities, those with chronic medical conditions); and 2) implement and evaluate interventions, such as a presumptive approach to vaccination counseling and motivational interviewing, to improve adult vaccination counseling practices at all provider levels (e.g., scheduler, medical assistants, nurses, advanced practice clinicians, physicians) in order to decrease misinformation about vaccines, increase vaccine confidence, and ultimately increase adult vaccine uptake.

Internal Deadline
External Deadline
01/27/2023

RFA-ES-22-010: 2023 Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)

UArizona is ineligible to apply to the 2023 deadline due to an existing/pending award. Contact RDS with questions

Internal Deadline
External Deadline
04/19/2023

RFA-IP-23-002: 2023 Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Notice of Funding Opportunity (NOFO) is to support research to identify and evaluate the effectiveness of quality improvement interventions specifically targeting adult immunization providers and to understand and develop approaches for immunization programs to support these efforts. This NOFO supports the Immunization Services Division and National Center for Immunization and Respiratory Diseases (NCIRD) priorities of improving adult immunization, particularly among the priority populations established by NCIRD which include: 1) racial and ethnic minority populations; 2) pregnant persons; 3) rural communities; and 4) adults with chronic medical conditions.

Internal Deadline
External Deadline
12/14/2022 (required LOI)

RFA-ES-21-001: 2023 Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional)

Pharmacy: M. Dodson
CALS: C. Zhou

 

The Outstanding New Environmental Scientist (ONES) Award is intended to identify the most talented Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the Environmental Health Sciences and assist them in launching an innovative research program focused on understanding the effects of environmental exposure on people’s health.

The ONES program is designed to identify outstanding scientists at the formative stages of their career and assist them in launching an innovative research program with a defined impact in the environmental health sciences. These R01 research grants are targeted for researchers who are defined by the NIH as Early Stage Investigators.

Internal Deadline
External Deadline
02/24/2023

PAR-20-103: January 2023 Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

This funding opportunity announcement (FOA) is designed to support highly integrated research teams of three to six PDs/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development are not appropriate for this FOA.

Internal Deadline
External Deadline
01/27/2023

PAR-22-220: 2022 Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed)

J. Wertheim

Contact RDS with questions

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

  • Courses for Skills Development
  • Research Experiences

This Funding Opportunity Announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical research education and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research education programs will incorporate extensive research experiences and well-designed courses for skills development to prepare recent baccalaureates from diverse backgrounds to transition into and complete rigorous, research-focused biomedical doctoral degree programs (e.g., Ph.D. or M.D./Ph.D.). This program is limited to applications from doctoral degree-granting institutions that are research-intensive (i.e., those with NIH research project grant (RPG) funding averaging greater than or equal to $7.5 million in total costs per year over the last three fiscal years).

This FOA does not allow appointed participants to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

Internal Deadline
External Deadline
01/31/2024

2023 Brain Research Foundation Seed Grant Program

M. Bhattacharya

Brain Research Foundation (BRF) is inviting eligible US academic institutions to nominate one (1) faculty member to submit a Letter of Intent (LOI) for the BRF Seed Grant Program. Nominated candidates must submit a completed LOI by December 23, 2022.

BRF’s Seed Grant Program was initiated in 1981. The purpose of the Program is to provide start-up money for new research projects and innovative programs that have the potential of becoming competitive for an NIH grant or other external funding sources. Our goal is to have this initial effort succeed in opening future opportunities for research, collaboration, and scientific advancement.

To be eligible, the PI must be a full-time Assistant or Associate Professor working in the field of neuroscience. Each total award is limited to $80,000 (direct costs) for a two-year grant period. The first grant payment of $40,000 will be made upon completion of the Seed Grant Acceptance Form May 2023). The final payment of $40,000 will be made contingent upon receipt of a Preliminary Progress and Financial Report (June 2024). The support focus is for new research projects of the highest scientific merit.

Please note that a medical school falls under its larger university and BRF will consider them a single institution.

To be eligible, the PI must be working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease.

Internal Deadline
External Deadline
12/23/2022
Solicitation Type